| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |